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Sllmmal'y 
Murine T cell responses to human class II major histocompatibility complex (MHC) molecules 
were shown to be a minimum of 20-70-fold lower than responses to allogendc molecules. Transgenic 
mice expressing slightly below normal (75-95%)  or very high (250-380%)  cell surface levels 
of human CD4 were utilized to determine whether this was due to a species-specific interaction 
between murine CD4 and class II molecules. Human CD4 was shown to function in signal 
transduction events in murine T cells based on the ability of anti-human CD4 antibody to synergize 
with suboptimal doses of anti-murine CD3 antibody in stimulating T cell proliferation. In mice 
expressing lower levels of human CD4, T cell responses to human class II molecules were enhanced 
up to threefold, whereas allogeneic responses were unaltered. In mice expressing high levels of 
human CD4,  responses to human class II molecules were enhanced at least  10-fold,  whereas 
allogeneic responses were between one and three times the level of normal responses. The relatively 
greater enhancement of the response to human class II molecules in both lines argues for a preferential 
interaction between human CD4 and human class II molecules. In mice expressing lower levels 
of human CD4, responses to human class II molecules were blocked by antibodies to CD4 of 
either species, indicating participation by both molecules. In mice expressing high levels of human 
CD4, responses to both human and murine class II molecules were almost completely blocked 
with anti-human CD4 antibody, whereas anti-routine CD4 antibody had no effect. However, 
anti-routine CD4 continued to synergize with anti-CD3 in stimulating T cell proliferation in 
these mice. Thus, overexpression of human CD4 selectively impaired the ability of murine CD4 
to assist in the process of antigen recognition. The ability of human CD4 to support a strong 
allogeneic response under these conditions indicates that this molecule can interact with murine 
class II molecules to a significant extent. Despite the fact that human CD4 appeared to be the 
only functional coreceptor in these mice, responses to human class II molecules were still much 
lower than those to murine class II alloantigens. This indicates that species-specific interactions 
between class II molecules and CD4 expressed on peripheral T cells are not suf~cient to account 
for the low xenogeneic response and that intrinsic differences in T  cell receptor structures or 
the need for species specificity in the interaction between CD4 and class II molecules during 
positive selection are also important. 
T 
he response of T cells of one species to cells of another 
has been shown to be restricted entirely to recognition 
of the MHC products on the stimulator cells (1-3). Similar 
to allogeneic and MHC-restricted responses, proliferative re- 
sponses  to xenogeneic class II MHC are generally mediated 
by CD4 + lymphocytes (4,  5),  whereas CTL responses to 
xenogeneic class I molecules are mediated by CD8 + cells (5, 
6). Such responses are directed against "alloantigenic" deter- 
minants rather than to species-specific  epitopes as demonstrated 
by the predominant response of xenogeneic T cells to poly- 
morphic determinants of the MHC antigens of another spe- 
des (1, 2, 5, 7-11). However, murine T cell responses to human 
class I (12,  13) and class II molecules (2-4,  14) are one to 
two orders of magnitude lower than responses against al- 
logeneic MHC molecules. 
Thymic MHC molecules have been shown to participate 
in the positive selection of MHC-restricted (15-17) and al- 
loreactive (18) T cells. Thus, one possible explanation for the 
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the absence in the murine thymus of a restriction dement 
capable of selecting appropriate T  cell receptors.  However, 
the frequencies of CTL precursors responding to human dass 
I molecuhs in human class I transgenic mice were comparable 
to those of normal mice (19, 20).  Similarly, expression  of 
the human DQ3.2 molecule in transgenic mice did not en- 
hance their response to human class II molecules (14). These 
results indicate that the expression of human MHC mole- 
cules in the thymus does not enhance the selection of human 
MHC-specific murine T  cells. 
Another possible explanation is based on the low sequence 
homology  between routine and human homologues of CD4 
(21), which might result in low avidity interactions between 
a T cell and a stimulator cell of a different species. Thus, the 
low frequency of murine T cells responding to human MHC 
molecules could be due to a poor interaction between the 
routine CD4 and CD8 coreceptor molecules and human dass 
II and class I molecules, respectively. This hypothesis is sup- 
ported by studies showing enhanced murine CTL responses 
to human class I molecules when the or3 domain was replaced 
with one of murine origin (20,  22, 23).  However, in other 
studies, the spedes of origin of the ol 3 domain of class I 
molecules did not influence the frequency of CTL precursors 
or the efficiency of T  cell recognition (13, 24, 25).  In this 
paper, we have investigated whether the low routine T cell 
response to human class II molecules is due to species specificity 
in the binding of murine CD4. In contrast to previous ap- 
proaches, we have utilized transgenic mice expressing human 
CD4 in order to determine the influence of this molecule 
on responses to both human and murine class II molecules. 
Materials and Methods 
Transgenic Mice.  Constructs containing the human CD4 gene 
were microinjected  into fertilized  eggs from (C57BL/6 x  CBA)Fz 
mice, and positive founder mice from each transgenic line were 
backcrossed with C57BL/6 (H-2  b) mice four to five times. Line 
37 contains approximately three copies of the human CD4 gene 
expressed under  the control  of the proximal p56  kk promoter, 
whereas line 996 contains approximately  20 copies expressed under 
the control of the CD3 6 enhancer and promoter (Grass, D, S., 
A. Garvin, D. Littman, N. Lee, and E. Lacy,  manuscript submitted 
for publication). Northern analysis  has indicated that human CD4 
gene expression  is primarily restricted  to T cells. HLA-DQ3.2 trans- 
genic mice were generated as previously described using fertilized 
eggs from C57BL/10 (H-2  b) mice (14). The DQ3.2  molecule is 
expressed on splenic B cells at slightly higher levels  than those found 
on human PBL (data not shown). 
Celt Lines.  A20.2J  is a BALB/c  (H-2a)--derived B cell line. The 
human B lymphoblastoid cell lines CltL (26) (HLA-A negative, 
-B negative, -Cw4, -DR8, -DPw4, DQ3) and LCL 721.221 (27) 
(class I negative, -DR1, -DQ1, -DP2) were immunosehcted for 
loss of expression of class I MHC molecules. 
Monoclonal Antibodies.  Leu3a  (anti-human  CD4)  (gift of L. 
Lanier; Becton Dickinson and Co., Mountain View, CA), GK1.5 
(anti-murine  CD4),  L243 (anti-HLA-DR monomorphic), and 
34-2-12 (anti-H-2D d) were purified and used at a final concentra- 
tion of 20 Izg/ml). 145-2-Cll (anti-routine CD3), 2.43 (anti-mu- 
fine CD8) and MKD6 (anti-I-A  a) were used as culture superna- 
tants, whereas IV-D-12 (anti-HLA-DQ  monomorphic) was used 
as a 1:100 dilution of ascites fluid. 
Cell-Surface Expression of CD4.  Murine spleen cells or human 
PBL were incubated with Leu3a or GK1.5 antibody in RPMI 1640 
containing 5% FCS and 0.02% sodium azide for 30 rain at 4~ 
Ceils were washed twice and incubated with a 1:50 dilution of 
fluorescein-conjugated  goat anti-mouse IgG antibody, Fc specific 
(Cappd Laboratories, Cochranville,  PA). After two washes, the cells 
were fixed with 0.5% paraformaldehyde  in PBS. Fluorescence  in- 
tensity was determined using a FACScan  | 
Mixed Lymphocyte Respons~  Spleen  cells (5  x  10  s) from trans- 
genic mice or littermate controls were cultured with the indicated 
numbers of irradiated B cell lines or spleen cells in RPMI 1640 
containing 10% FCS and 5  x  10 -s M 2-ME in 96-well plates. 
Cells were cultured in the presence or absence of the indicated an- 
tibodies. Cultures were maintained for 4 d at 37~  and pulsed with 
1 ~Ci of [3H]thymidine  for the last 16-18 h. Cells were harvested 
onto glass  fiber  filters  using a PhD cell  harvester and counted, ti~ults 
represent the mean of triplicate cultures (• SD) after subtraction 
of background  responses of stimulator cells in the absence of 
responders. 
Antibodymediated T CellProliferation.  The ability of antibodies 
to human and murine CD4 to synergize  with suboptimal concen- 
trations of anti-CD3 antibodies was determined as previously de- 
scribed (28, 29). Flat-bottomed 96-well plates were coated with 
10 ~g/ml of sheep anti-mouse IgG with or without 10 ~g/ml of 
rabbit anti-rat IgG antibody at 4~  After washing the plates to 
remove  unbound antibody,  0.2 ~g/ral of  l.eu 3a (binds to anti-mouse 
IgG) or a 1:100 dilution of GK1.5 culture superuatant (binds to 
anti-rat IgG) was added simultaneously with the indicated dilu- 
tions of 145-2-Cll antibody (binds to anti-mouse IgG). As nega- 
tive controls either X63 culture supernatant that contains murine 
IgG or 0.2 ~g/ml of rat IgG were added together with various 
dilutions of 145-2-Cll. After I h at 37~  unbound antibody was 
removed, and 3 x  104 purified T cells from either transgeoic mice 
or littermate controls were added to each well. T cells  were purified 
by adherence to plastic for 1 h, nylon wool column passage, and 
treatment  with anti-I-A  h antibody 25-5-16 plus rabbit comple- 
ment to deplete remaining B ceils. T cell purity was determined 
to be >92% by staining with antibody to CD3, Cells were cul- 
tured with 100 U/nil of  riD2 for 4 d, pulsed for the last 16 h with 
1 IzCi of [3H]thymidine, and harvested onto glass fiber filters. 
Results represent the mean of triplicate cultures (+SD). 
Results 
Expression of  Human CD4 Molecules in Transgenic  Mic~  The 
level of cell surface expression of human CD4 in transgenic 
mice from lines 37 and 996 was compared to its level of ex- 
pression on human PBL by flow cytometry. Analysis of four 
mice from each of the two transgenic lines in different ex- 
periments revealed  that line 37  expresses  human CD4  at 
75-95% of the levd found on human PBL from three different 
donors (Fig.  1 A). The level of human CD4 expression in 
purified T cells from line 996 was three- to fourfold the levd 
found on T  ceils from line 37  (Fig.  1 B) and 2.5-3.8-fold 
the level found on human PBL (Grass, D. S., A. Garvin, D. 
Littman, N. Lee, and E. Lacy, manuscript submitted for pub- 
lication). By comparison with normal littermates, the per- 
centage of calls expressing routine CD4 and CD8 was not 
altered in either of these two lines (Grass, D. S., A. Garvin, 
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Figure 1.  Level  of expression of human and murine  CD4 in transgenic 
mice. (A) Human  CD4 expression  on spleen cells from  line  37 transgenic 
nfice (solid line) and human  PBL (dotted line). (B) Human  CD4 expression 
on purified  T cells from  line 996 (solid line) and from line 37 (dotted line). 
Forward  angle  light  scatter  profiles  for all cells  were  comparable, indicating 
that the ceils  are of  similar  size. Experimental  details  are given  in Materials 
and Methods. 
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D. Littman, N. Lee, and E. Lacy, manuscript submitted for 
publication). However, in both lines the level of expression 
of routine CD4 was reduced by 50%. 
Participation  of Human CD4 in Signal Transduction Events.  It 
has been previously shown that T calls cultured in the pres- 
ence of suboptimal concentrations of anti-CD3 or anti-TCR 
antibodies can be induced to proliferate by the simultaneous 
addition of antibodies to CD4 or CD8 (28,  29),  indicating 
that crosslinking CD4 or CD8 with the TCR triggers signal 
transduction events and results in T cell activation. This ex- 
perimental assay was utilized to determine whether human 
CD4 expressed in transgenic mice interacts with routine com- 
ponents involved in signal transduction and proliferation. 
Simultaneous addition of anti-human CD4 antibody with 
concentrations of anti-CD3 antibody that do not stimulate 
T cell proliferation alone (Fig. 2 A) resulted in strong prolifer- 
ative responses in T cells from both transgenic lines (Fig. 2 
/3). Comparable levels of T cell proliferation were obtained 
with 2.2-fold less anti-CD3 antibody in line 996 as compared 
to line 37, whereas the former expressed  three- to fourfold 
as much CD4. T  ceils from littermate control animals did 
not  proliferate  in  response  to  simultaneous  additions  of 
anti-human CD4 and anti-CD3 antibodies (Fig. 2 B). These 
results indicate that human CD4 expressed in transgenic mice 
interacts with murine components required for T  cell acti- 
vation. 
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Figure 2.  Human  CD4 synergizes  with murine  CD3 to induce  prolifer- 
ation. Purified  splenic T cells from littermate  control (open squares), line 
37 (open circles), and line 996 (closed circles) were cultured in plates coated 
with serial dilutions  of anti-CD3 together  with either a negative  control 
antibody (A) or anti-human CD4 (B) in the presence of 100 U/ml of 
recombinant  ID2 for 4 d. Bars, SD. Further  experimental  details  are given 
in Materials and Methods. 
T  CellResponses  to Class IIMolecules  in Human  CD4  Trans- 
genic Mice  It has been previously demonstrated that mu- 
fine T call responses  to human class II molecules are much 
lower than responses  to allogeneic class II molecules (4,  14, 
30).  In normal C57BL6 (H-2  b) mice, T  cell responses  to 
human class II-positive B cell lines C1R and 721.221 were 
still considerably lower than responses to the allogeneic rou- 
tine B cell line A20.2J even when 35 times more human stimu- 
lator cells were used (Fig. 3, compare open triangles in A-C). 
In other experiments, significantly  lower responses have been 
observed using up to 70 times more human cells (data not 
shown).  These  allogeneic and xenogeneic responses  were 
shown to be primarily directed at class II molecules based 
on their inhibition by antibodies directed against I-A  a and 
HLA-DR, respectively (Table 1). Anti-D  a antibody had no 
effect on the allogeneic response, whereas the cell lines used 
for xenogeneic stimulation were largely or entirely class I 
negative. The low response to human class II molecules was 
not due to a low level of surface expression, since FACS  | 
analysis using several mAbs indicated that 721.221 and C1R 
expressed  similar or higher class II levels than those found 
10  4  10  4  10  s  10  ~ 
Stimulators/well 
Figure 3.  Responses  to human  and routine  class  II mol- 
ecules in normal and CD4 tramgenic  mice. Spleen cells 
from line 996 (closed circles), line 37 (open circles), and lit- 
termate  control (open triangles) were  cultured  for 4 d with 
the indicated  numbers of irradiated lymphoblastoid  cell 
Frees. (,4) 721.221 (class I negative,  -DR1, -DQ1, -DP2). 
(B) CIR (HLA-A  negative, -B negative, -CW4, -DR8, 
-DPw4,DQ3).  (C)  A20.2J (H-2d). Each data point 
represents the mean of triplicate cultures after subtrac- 
tion of the proliferative  response  of  stimulator  cells  (150-- 
400 clan for A20.2J and CIR and 400-1500 Clan for 
721.221). Proliferative  responses in the absence of stimu- 
htors ranged from 180 to 300 cpm. Bars, SD. 
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Responder  [3H]thymidine uptake (A cpm) 
Stimulator  mAb  Specificity  B6  %  inh*  Line 37  %  inh  line 996  %  inh 
A20 (murine) 
721.221  (human) 
None  34,942  102,675  60,380 
MKD6  bA  d  12,454  64  16,709  84  13,594  77 
L243  DR  42,834  0  83,904  18  45,876  24 
34-1-2  D a  34,652  1  ND  63,967  0 
None  5,087  8,951  27,305 
L243  DR  2,212  56  5,348  40  3,452  87 
MKD6  I-A  a  3,640  28  ND  20,650  24 
34-1-2  D a  7,603  0  ND  47,927  0 
5  x  10  s responder spleen cells were stimulated with 6.25  x  10  a irradiated  (5,200 tad) A20 cells, 2,5  x  104 irradiated (9,000 red) 721.221 cells, 
or 5  x  10  s irradiated (2,800 rad) spleen cells from DQ3.2 transgenic mice either in the presence or absence of the indicated antibodies. Cells were 
cultured as described in Materials and Methods.  Data from line 37 is taken from a separate experiment  in which the control animal gave similar 
proliferative responses and inhibition  but was not included for simplicity. The data is representative of four independent experiments. Numbers represent 
the mean of triplicate cultures after subtraction of background responses of the stimulator cells only and generally had a SD of 4-20%. Background 
responses in the absence of stimulator cells ranged from 140 to 350 cpm. Antibodies  that do not react with stimuhtor ceils exhibited up to 28% 
inhibition in different experiments.  Thus, inhibition of g28% was considered to be nonspecific. Bold-faced numbers indicate significant inhibition. 
* inh, inhibition. 
on A20.2J (data not shown). To determine whether the dii~- 
ence in stimulation  was due to the species  of  cell  on which 
the  class  II  molecules  were  expressed,  T cell  responses  to  spleen 
cells  from HLA-DQ3.2  transgenic  mice and I-A  brat2  mice 
were examined. The response  to  HLA-DQ3.2 was still  lower 
than the  response  to I-A  bmlz  even when up to 25 times  more 
DQ3.2 stimulator  cells  were used (Fig.  4 A). These results 
indicate  that the murinc T cell  response to human class  II 
molecules is a minimum of 25-70-fold lower than the re- 
sponse to aUogencic class  II MHC  molecules,  based on the 
dose of  stimulator  cells  required  to  give  equivalent  responses. 
Because  culture  conditions  did  not allow  addition  of  suf~dent 
cells to give a convincing xenogeneic response, the actual differ- 
ence is almost certainly much greater than this value. The 
difference between allogeneic and xenogeneic responses is not 
due to the species of origin of the stimulator ceils but instead 
reflects structural differences between murine and human class 
II molecules. 
To determine whether the low responses observed in normal 
mice were due to a failure of murine CD4 to interact with 
human class II molecules, spleen cells from human CD4 trans- 
genic mice were examined.  In line 37 mice, which express 
a slightly lower than  normal level  of human  CD4,  T  cell 
responses to the human class II molecules present on 721.221 
(Fig. 3 A) and CIK (Fig. 3 B) were either slightly augmented 
or unaltered as compared to responses of littermate controls. 
However, in line 996 mice, which express a high level of human 
CD4,  the responses to 721.221  and CIR were enhanced at 
least 10-fold, based on the doses of stimulator cells required 
to give equivalent responses (Fig. 3, A  and B). Our ability 
to compare T  cell responses to spleen cells expressing the 
human HLA-DQ3.2 molecule was limited by the high number 
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Figure 4.  Responses to allogeneic and human class II 
transgenic spleen cells  in normal and CD4 transgenic mice. 
Spleen  cells  from bin12 mice (open circles) and DQ.3.2 trans- 
genie mice (closed circles),  both of which share the same 
background (H-2  b) were used as stimulators. Responder 
spleen cells were from (A) normal littermate control; (B) 
line 37; and (C) line 996. Cells were cultured as described 
in Fig. 3. 
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tion and the relatively low xenogeneic responses obtained in 
all cases. Indeed, no observable response was ever detected 
in the littermate controls (Fig. 4). However, significant and 
increasing responses were observed at the highest stimulator 
doses used, in line 37 and line 996 (Fig. 4). In line 37 mice, 
responses to the allogeneic class II molecules expressed on 
A20.2J (Fig. 3 C) and I-A  ~12 spleen cells (Fig. 4, compare 
A  and B) remained unaltered as compared to responses of 
normal littermate controls. In different experiments using line 
996, allogeneic responses were either unaffected (compare Fig. 
4, A  and C, and data not shown) or enhanced 1.5-fold to 
threefold (Hg. 3 C, and data not shown). The relatively  greater 
enhancement  of the response to human class II molecules sug- 
gests that human CD4 preferentially interacts with human 
class II molecules. 
Despite the augmentation observed in line 996, the highest 
response to the human B cell lines 721.221 and CIR was still 
significantly less than the response to A20.2J. AUogeneic re- 
sponses comparable in magnitude to the highest observed 
xenogeneic responses in line 996 were achieved using 16-33- 
fold fewer stimulator cells (compare Fig. 3, A and B, with 
C). In line 37, the level of the xenogeneic response was still 
so low that an accurate comparison could not be made. Simi- 
larly, maximal observed responses to DQ3.2 expressing mu- 
rine spleen cells were comparable or less than those achieved 
using 20-fold fewer I-A  bin12 expressing cells. Therefore, this 
difference was not due to the species of origin of the stimu- 
lator  cell.  Expression  of human  CD4  did  not  alter  the 
specificity of these allogeneic and xenogeneic responses for 
class II molecules (Table 1). Thus, in every combination tested, 
responses to human class II molecules remained substantially 
lower than allogeneic responses in the same mice. 
Participation of  Huraan and Murine CD4 in Responses to Class 
II Molecules.  The relative contribution of human and mu- 
fine CD4  to T  call responses was examined by antibody 
blocking. As expected in normal mice, the response to class 
II ailoantigens  expressed  on A20.2J was blocked with anti-mu- 
fine CD4, but not by antibody against murine CD8 or human 
CD4 (Table 2). The response to the human class II molecules 
expressed on 721.221 was also inhibited by anti-routine CD4 
to a comparable extent. In line 37 mice, responses to human 
class II molecules expressed in 721.221 were partially blocked 
by both anti-murine and anti-human CD4 (55% and 58%, 
respectively).  In contrast, allogeneic  responses to A20.2J (Table 
2) and I-A  bin12 (data not shown) were blocked by antibodies 
against murine but not human CD4. Surprisingly, anti-mu- 
rine CD8 also reproducibly inhibited the response to A20.2J 
in line 37. Anti-routine CD8 did not inhibit the xenogeneic 
response in these mice.  The response to A20.2J  was still 
directed at class II and not class I molecules (Table 1). Pos- 
sible reasons for this observation are discussed  below. Nonethe- 
less, the difference in patterns of inhibition of allogeneic and 
xenogeneic  responses in line 37 are inconsistent with the no- 
tion that blockade is due to "negative signal transduction" 
and instead suggest that they reflect interference with ligand 
binding. 
Interestingly, T cell responses of line 996 to either human 
or murine class II molecules were blocked only by anti-human 
CD4  antibodies,  whereas  neither anti-murine CD4  nor 
anti-murine CD8 had any effect. These results indicate that 
high level expression of human CD4 in this line impairs its 
ability to support normal responses to murine class II alloan- 
tigens, as well as human class II molecules. However, the level 
of aUogeneic responses observed in these mice suggests that 
high-level expression of human CD4 is able to replace the 
Table  2.  Antibody Sensitivity of the T  Cell Response to Class II Antigens in Human CD4  Transgenic Mice 
Responder [3H]thymidine uptake (A cpm) 
Stimulator  mAb  Specificity  B6  %  inh*  Line 37  %  inh  line 996  %  inh 
A20 (murine) 
721.221  (human) 
None  34,942  102,675  60,380 
GK1.5  Murine CD4  10,148  71  55,597  46  74,126  0 
Leu3a  Human  CD4  32,785  6  137,393  0  5,643  91 
2.43  Murine CD8  29,040  17  40,785  60  49,215  18 
None  5,087  8,951  27,305 
GK1.5  Murine CD4  1,631  68  4,041  55  27,440  0 
Leu3a  human  CD4  6,052  0  3,773  58  3,083  89 
2.43  Murine CD8  5,276  0  8,152  9  28,803  0 
5  x  10  s responder spleen cells  were stimulated with 6.25  x  103 irradiated (5,200 rad) A20.2J cells or with 2.5  x  103 irradiated (9,000 rad) 721.221 
cells either in the presence or absence of 50/~1 of culture supernatant containing the indicated antibodies in a total volume of 200 #1. Cells were 
cultured as described in Materials and Methods. Data from line 37 is taken from a separate experiment in which the control animal gave similar 
proliferative responses and inhibition but was not included for simplicity. Numbers represent the mean of triplicate cultures after subtraction of responses 
of stimulator cells only and generally had a SD of 4-20%. Background responses in the absence of stimulator cells ranged from 140 to 350 cpm. 
Bold-faced numbers indicate specific inhibition. 
* inh, inhibition. 
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Synergism between murine CD4 and CD3 is diminished by 
overexpression of human CD4. Purified T cells from normal littermate 
control (open squares), line 37 (open circles), and line 996 (closed circles) were 
cultured in plates coated with sheep anti-mouse IgG and rabbit anti-rat 
IgG together with various dilutions of anti-CD3 and a 1:100 dilution of 
anti-routine CD4 supernatant. Background response to rat IgG control 
were subtracted from the responses against murine CD4. At the highest 
concentrations of anti-CD3 antibody, these responses were 40,000 cpm 
and ranged from 450 to 4,000 cpm at the three lowest  dilutions. Bars, SD. 
normal function of murine CD4. To determine whether the 
impairment  was due to competition for factors involved in 
signal transduction,  the ability of anti-murine  CD4 to syn- 
ergize with suboptimal concentrations of anti-CD3 was ex- 
amined. Proliferative responses in line 37 were similar to those 
of normal mice (Fig.  5). This indicates that the signal trans- 
duction function of murine CD4 in line 37 is comparable 
to that  of normal  spleen cells.  However, T  cells from line 
996 required 2-10 times more anti-CD3 antibody than T cells 
from line 37 to synergize with anti-murine  CD4 antibody 
in  stimulating  comparable  levels  of T  cell  proliferation. 
Nonetheless, maximal proliferative responses in line 996 were 
similar to those of line 37 and normal mice. This indicates 
that the ability of murine CD4 to participate in signal trans- 
duction events has been somewhat reduced but not abolished. 
Discussion 
In this paper, human CD4 transgenic mice were utilized 
to determine whether low murine T cell responses to human 
class II molecules were due to a failure of murine CD4 to 
bind to these molecules. This approach  differs  from those 
previously employed to address this issue. Two different lines 
of transgenic mice were utilized,  one of which expressed a 
slightly lower than normal amount of human CD4, whereas 
the other expressed a relatively high level. In both lines,  the 
human  CD4 molecule was able to synergize with murine 
CD3 in T cell activation, and the level of activation achieved 
was correlated with the amount of human CD4 expressed. 
In addition,  in the transgenic line expressing high levels of 
human CD4, antibody against murine CD4 no longer blocked 
antigen recognition and its ability to synergize with murine 
CD3 was somewhat reduced. The exact mechanisms involved 
in the synergistic response have not been determined. How- 
ever, it seems most likely to result from an interaction be- 
tween  CD4  and  p561ok, as  well as  additional  interactions 
with components of the TCR complex. Our data would thus 
suggest that human CD4 can interact with both p56  ~k and 
the TCK in transgenic T  cells, and can effectively compete 
with  murine  CD4  for p561r  binding  and  TCR  access in 
order to enable its participation  in T  cell responses. Addi- 
tional support for this conclusion comes from previous studies 
that  have demonstrated  that  murine p56  Ick associates  with 
human  CD4 in a transient  coexpression system (31). 
Although suggesting that human CD4 does interact with 
these components, our data do not directly indicate whether 
the level of interaction is comparable to that of routine CD4. 
Indeed, a comparison of the data in Figs. 2 and 5 might sug- 
gest that there is a greater degree of synergism between CD3 
and routine CD4 than between CD3 and human CD4. How- 
ever, this comparison is not valid because of necessary differ- 
ences in the protocols used to attach the antibodies to the 
plates. In particular,  anti-human CD4 and anti-CD3 are both 
attached  to the plates  through  binding  to the same sheep 
anti-mouse secondary antibody on the culture plates, whereas 
anti-murine  CD4 is attached via an anti-rat  reagent.  Our 
conditions were optimized to give adequate synergism de- 
spite competition between anti-CD3 and anti-human  CD4 
for available binding sites.  In addition,  we have noted that 
not all antibodies against  CD4 and CD8 are equivalent in 
their ability to synergize with anti-CD3  (our unpublished 
data).  Nonetheless, we feel that the ability of human CD4 
to effectively compete with murine CD4, combined with its 
ability to support allogeneic responses (discussed below), in- 
dicate a significant level of function for this molecule in trans- 
genic mice. 
The participation of human CD4 in murine T cell responses 
is also indicated by antibody blocking experiments.  In the 
line expressing relatively low levels of human CD4, antibodies 
against this molecule blocked recognition of human, but not 
murine class II molecules. In the line expressing high levels, 
anti-human  CD4 antibodies blocked responses to the class 
II molecules of both species, whereas antibodies against mu- 
rine CD4 were without effect. Because murine  CD4 con- 
tinued to synergize with CD3 under these conditions,  this 
result is not due to an inability to transduce signals leading 
to T  cell activation.  In addition,  the specificity of antibody 
blocking observed in these experiments is inconsistent with 
an inhibitory mechanism based on negative signal transduc- 
tion. Instead, inhibition appears to represent direct interfer- 
ence with the interaction between CD4 and class II mole- 
cules, and thus reflects the degree to which murine and human 
CD4 participate in antigen recognition.  One incongruous 
observation was the unexpected but reproducible ability of 
anti-murine  CD8 to inhibit the response to allogeneic class 
II molecules in line 37 mice. However, this same antibody 
failed to block the response to human class II molecules in 
the same mice, and had no effect on class II specific responses 
in normal and line 996 transgenic mice. Again, this specificity 
of the inhibition is inconsistent with a negative signal trans- 
duction mechanism.  Although the exact mechanism is not 
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subset, which in these mice also expresses  human CD4. Efforts 
to examine the specifidty and responsiveness of this subset 
are in progress. 
Additional evidence of the ability of human CD4 to func- 
tion as an effective coreceptor was provided by the observa- 
tion that it augments antigen recognition in both transgenic 
lines. Responses to human class II molecules expressed on 
two different human B cell lines were enhanced up to three- 
fold in the line expressing a relatively low level of human 
CD4, and a minimum of 10-fold in the high-level expresser. 
Responses to HLA-DQ3.2-expressing  transgenic spleen cells 
were somewhat enhanced in both lines but to a lesser extent. 
This probably reflects the lower level of class II expression 
on spleen cells compared to B lymphoblastoid lines, as well 
as technical limitations on the number of spleen cells that 
could be added to cultures.  Nonetheless,  the aUogeneic re- 
sponse in the same animals was either unaffected  or augmented 
to a significantly smaller degree. It should be noted that the 
level of murine CD4 expression is reduced by 50% in both 
lines, but that the total CD4 density is higher than on normal 
animals. These results indicate that the level of allogeneic and 
xenogeneic responses cannot be simply correlated with the 
overall density of CD4 molecules regardless of their species 
of origin. Instead, the expression of human CD4 selectively 
augments responses to human class II molecules and argues 
for a preferential interaction between them. 
Despite the fact that routine CD4 expression is reduced 
by 50% in both transgenic lines, there is no reduction in the 
allogeneic response. This suggests  that either the reduced 
amount of murine CD4 is still sufficient to allow a normal 
response or that human CD4 is able to support the allogeneic 
response. An interaction between human CD4 and murine 
class II molecules is suggested by the normal to weakly aug- 
mented allogeneic response observed in line 996. Antibody 
blocking experiments indicate that this response is entirely 
dependent upon human and not murine CD4. It is impor- 
tant to recognize that the level of human CD4 expression 
in line 996 is significantly higher than normal. Therefore, 
these results do not in themselves allow an assessment of how 
well human CD4 binds to murine class II molecules. How- 
ever, in  combination with  the data on  augmentation of 
xenogeneic responses, we suggest that human CD4 binds to 
class II molecules of both species, but preferentially to those 
of human origin. 
Three previous studies have addressed the issue of human 
CD4 function and antigen recognition in routine T cell hy- 
bridomas. In one case, it was shown that human CD4 binding 
to human class II molecul-s on an antigen presenting cell 
could augment recognition of an unrelated antigen (32). This 
presumably occurs through an augmentation of intercellular 
adhesion.  In a second study, the ability of human CD4 to 
augment recognition of a human class II molecule by a mu- 
fine T cell hybridoma was shown (33). However, in neither 
case was the recognition of mnrine class II molecules assessed. 
In a third study, it was found that transfection  of human 
CD4 into a routine T cell hybridoma was as effective  as trans- 
fection of routine CD4 in restoring recognition of murine 
class II molecules (34). Our data are not inconsistent  with 
this conclusion, particularly if the level of human CD4 ex- 
pression is high. 
The data presented here also establish that antibody against 
murine CD4 blocks the response of normal C57BL/6 mice 
and of line 37 transgenics to both murine and human class 
II molecules. This suggests that murine CD4 does interact 
at some level with human class II molecules. This result ap- 
pears to conflict with a previous report that murine CD4 
does not functionally  interact with human class II molecules 
(35). Furthermore, it appears inconsistent with the hypoth- 
esis on which the present study was based, i.e., that murine 
CD4 does not bind to human class II molecules. However, 
in the study cited (35), CD4 function did not require its in- 
teraction with the TCR, but only the ability to augment 
intercellular adhesion. It is also important to recognize that 
as with human CD4, the species specificity of murine CD4 
may be preferential rather than absolute.  The response to 
human class II molecules that is blocked by anti-murine CD4 
is very weak, and this could reflect a limited participation 
by the routine CD4 molecule. The ability of human CD4 
to specifically  augment responses to human class II molecules 
provides further evidence that a poor interaction with rou- 
tine CD4 molecules plays a role in limiting the xenogeneic 
response. 
Despite the fact that expression of human CD4 augments 
murine T cell responses to human class II molecules, these 
never reached the level of the responses to allogeneic class 
II molecules. The augmentation observed in line 37 was sur- 
prisingly modest, because the level of human CD4 expres- 
sion in these mice approximated that found on normal human 
PBL. This could indicate that although human CD4 func- 
tions  in  the  murine T  cell  environment, it  is  relatively 
ineflficient  in comparison with murine CD4. However, in line 
996, the response to human class II molecules was still 16-33- 
fold lower than the allogeneic response. This was so despite 
the fact that the high-levd expression of human CD4 had 
uncoupled murine CD4 from the process of antigen recog- 
nition, and human CD4 fully supported the allogeneic re- 
sponse. These results indicate that the poor xenogendc re- 
sponse  cannot  be  overcome  simply  by  optimizing 
species-spedfic interactions  between class II molecules and 
the CD4 molecules expressed on peripheral T cells. This con- 
clusion is in accord with earlier work from this laboratory 
in which xenogeneic responses to human class I molecules 
were examined utilizing human/mouse chimeric class I mol- 
ecules (13), but contrasts  with similar studies in which it 
was concluded that weak responses to xenogeneic MHC class 
I molecules were due to failure of CD8 to interact with HLA 
class I molecules and not to the selection of the mouse T 
cell repertoire  (20). Instead,  we conclude that  the weak 
xenogeneic response to both class I and class II molecules 
must reflect intrinsic differences in routine and human T cell 
receptor structure, or the need for dual expression of human 
coreceptors and MHC molecules for optimal selection of 
human MHC-specific T cells during thymocyte  development. 
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